학술논문
Safety, tolerability, and preliminary efficacy of SYN120, a dual 5-HT6/5-HT2A antagonist, for the treatment of Parkinson disease dementia: A randomized, controlled, proof-of-concept trial
Document Type
Article
Author
Source
In Parkinsonism and Related Disorders September 2023 114
Subject
Language
ISSN
1353-8020